Vector-based vaccine tech firm Vaccitech has secured £20m ($27.1m) in venture capital with investors Google Ventures, Sequoia China, Neptune Ventures and Oxford Sciences Innovation.
3-D microparticles which degrade at differing rates in the body could allow multiple doses of drugs or vaccines to be administered in a single injection, say MIT researchers.
Drug industry efforts to develop a Zika vaccine are accelerating but it will be at least 18 months until the first candidates are ready for trials according to the WHO.
Speculation GSK's meningitis B vaccine Bexsero will soon be available on the UK National Health Serivice will be welcomed by campaigners, protein supplier Sandoz and its parent company, Novartis.
UPDATE: Merck says switching cell lines would impact safety and quality
The anti-abortion group that blames Merck & Co for the recent US measles outbreak says it would not judge parents who have children vaccinated with MMR II for the good of society.
Manufacturers developing Ebola vaccines will be immune from lawsuits following a decision by US HHS (Health and Human Services) to issue a declaration on the matter.
in-PharmaTechnologist presents its round-up of the latest in the world of drug delivery, including news from Sanofi Pasteur, Haselmeier, Unigene, and Southwest Research Institute.
Inovio Biomedical has developed a hand-held, cordless electroporation device, Cellectra-SP, which it believes is well suited to administering DNA vaccines in mass immunization programmes.
In the next week the Chinese SFDA is expected to approve licences for two locally produced H1N1 vaccines, which unlike some alternatives only require one dose to confer immunity.
The growth of the Chinese vaccine market is set to outstrip the country’s pharma sector, according to a Frost & Sullivan (F&S) report that predicts 14-15 per cent CAGR.
Novartis is looking to buy an additional 39 per cent of its majority-owned subsidiary Novartis India for around 4.4bn rupees ($87m), or 351 rupees per share.
Dr Rajashekar Reddy, chief minister of Andhra Pradesh, India presided over the inauguration ceremony for Biological E’s new INR3bn ($61m) vaccine and biopharmaceuticals manufacturing campus.
India’s health authorities may invest RPS5bn ($102m) to re-open three state run vaccine manufacturing firms in a bid to combat current shortages, according to reports in the country’s media.
Merck has been hit with a contamination threat prompting the recall
of a million of its childhood Hib vaccines across the US, right
alongside the Canadian suspension of its MMR vaccine.
In the US, the New York Senate last week passed that would prohibit
the administration of any vaccine containing more than a trace
amount of mercury to children under the age of three or pregnant
women.
The European Investment Bank (EIB) is planning to lend around €40
million to Germany's Impfstoffwerk Dessau-Tornau - a developer and
contract manufacturer of pharmaceutical and veterinary medicines -
to help it build a new research...
Strasbourg, France-based Aventis has signed a research, option and
license agreement with Vivalis of the USA for the manufacture of
vaccine candidates using avian stem cell technology.